Decline in Flu Vaccination Rates Among U.S. Adults from 2020 to 2024

A recent study highlights a significant decline in flu vaccine uptake among U.S. adults from 2020 to 2024, driven by shifting attitudes and misinformation. Learn more about this concerning trend.
Between 2020 and 2024, there has been a notable decrease in influenza vaccine uptake among adults in the United States, as revealed by a recent study published in PLOS Global Public Health. Researchers Hannah Melchinger from UT Southwestern Medical Center and her team conducted two comprehensive, cross-sectional surveys to assess vaccination trends over these years.
In May 2020, more than 60% of U.S. adults surveyed reported having received or intending to receive the flu vaccine in the upcoming months. However, by October 2024, this figure dropped to 54%, indicating a substantial decline in vaccination willingness. The decrease was particularly evident among demographic groups typically showing higher vaccination rates. Older adults over 35 years experienced an 11% reduction, males saw a 13% decline, and white, non-Hispanic, and more highly educated individuals also exhibited decreased vaccination rates.
The authors attribute this downward trend to shifting attitudes and intentions related to vaccination, influenced heavily by the COVID-19 pandemic. Factors such as perceived risk changes, widespread vaccine misinformation, and disinformation appears to have contributed to the hesitation and reduced uptake.
This trend raises concerns about public health preparedness and highlights the importance of addressing vaccine misinformation and improving vaccination campaigns to protect vulnerable populations against seasonal influenza.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Long-Term Use of Desogestrel Contraceptive Associated with Slight Increase in Brain Tumor Risk
Prolonged use of the contraceptive pill desogestrel for over five years may slightly increase the risk of developing benign brain tumors, according to a French study. The risk diminishes after stopping the medication and is not observed with levonorgestrel. Experts suggest monitoring patients and discontinuing desogestrel if tumors are detected.
Innovative AI Tool Accelerates and Enhances Diagnosis of Endocrine Cancers
A novel AI-powered application is revolutionizing the detection of endocrine cancers, offering faster and more accurate diagnoses globally, including on basic devices like smartphones.
Empowering Advanced Practice Registered Nurses Leads to Better Health Outcomes, New Research Shows
Research shows that states granting full practice authority to nurse practitioners experience significantly better health outcomes and access to care, especially in underserved areas.
Innovative One-Dose Vaccine Strategy Boosts Immune Response Using Dual Adjuvants
A groundbreaking single-dose vaccine approach using dual adjuvants has shown to generate a diverse and potent immune response, promising advancements in immunization for various infectious diseases.